The Man Behind China’s Ebola Vaccine
Yu Xuefeng is among a wave of Chinese scientists returning from careers abroad to make the nation’s biomedical industry more globally competitive.
Breast Cancer Vaccine Trials Prove Scientific Success, But Not Legal
The results of a blind trial on a newly developed breast cancer vaccine, OBI-822, bear scientific and medical importance, but the drug is not allowed a permit under current regulations because it did not pass clinical trials. If OBI-822 passes future trials, Taiwan would be the first country in the world to develop a carbohydrate-based vaccine for breast cancer.